CTLT vs NPCE
CTLT (CTLT) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
CTLT (CTLT) common stock.
Neuropace Inc (NPCE) is a medical devices company listed on US.
CTLT does not have a complete income-statement cache yet.
Latest reported NPCE revenue for 2025-12-31 was $100.0M. Net income was -$21.5M. Revenue was up 25.1% from 2024-12-31 to 2025-12-31. NPCE currently screens at market cap $312.2M.
NPCE currently screens at market cap $312.2M.
Not investment advice. Open the CTLT and NPCE stock pages for the full models.
Not investment advice.